Pharmaceutical composition comprising valsartan

Details for Australian Patent Application No. 2004238546 (hide)

Owner Novartis AG

Inventors Glazer, Robert Dean; Maggioni, Aldo Pietro; Latini, Robert; Cohn, Jay Norman; Tognoni, Gianni

Agent Davies Collison Cave

Pub. Number AU-A-2004238546

PCT Pub. Number WO2004/101535

Priority 60/471,137 16.05.03 US

Filing date 14 May 2004

Wipo publication date 25 November 2004

International Classifications

C07D 257/04 Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/101535 Priority application(s): WO2004/101535

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238556-Method for producing a porous, carbonbased material

2004238538-Boat having a pedal drive